Skip to main content
HR 1260 108th Congress House Health Administrative fees Administrative procedure Agriculture and Food Animals Appropriations Collection of accounts Commerce Congress Congressional reporting requirements Department of Health and Human Services Drug approvals Drug industry Economics and Public Finance Feeds Government Operations and Politics Government paperwork Indexing (Economic policy) Law Performance measurement

Animal Drug User Fee Act of 2003

Introduced: March 13, 2003 See on congress.gov
 Everywhere this bill has been 15 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 2, 2003
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Oct 1, 2003
Motion to reconsider laid on the table Agreed to without objection.
Oct 1, 2003
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H9054-9057)
Oct 1, 2003
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H9054-9057)
Oct 1, 2003
DEBATE - The House proceeded with forty minutes of debate on H.R. 1260.
Oct 1, 2003
Considered under suspension of the rules. (consideration: CR H9054-9059)
Oct 1, 2003
Mr. Upton moved to suspend the rules and pass the bill.
Sep 30, 2003
Placed on the Union Calendar, Calendar No. 167.
Sep 30, 2003
Reported by the Committee on Energy and Commerce. H. Rept. 108-287.
Sep 10, 2003
Ordered to be Reported by Voice Vote.
Sep 10, 2003
Committee Consideration and Mark-up Session Held.
Mar 24, 2003
Referred to the Subcommittee on Health.
Mar 13, 2003
Referred to the House Committee on Energy and Commerce.
Mar 13, 2003
Sponsor introductory remarks on measure. (CR E462)
Mar 13, 2003
Introduced in House
 Plain-English summary Congressional Research Service
Animal Drug User Fee Act of 2003 - Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to assess and collect fees for an animal drug or a supplemental animal drug application (if it requires safety or effectiveness data). Requires payment upon submission or the application will be considered incomplete and not accepted. Excepts from payment applications which were previously filed but withdrawn or not approved without a waiver or refund.

Assesses annual fees on animal drug products, establishments, and sponsors.

Establishes a fee schedule for FY 2004 through 2008, including total fee revenues for animal drug products, establishments, and sponsors. Adjusts fees to reflect inflation, review workload, and operating reserves of carryover user fees (in the final year).

Directs the Secretary to establish before each fiscal year, based on the fee schedule revenue amounts and the adjustments, the following: (1) animal drug application fees; (2) supplemental animal drug sponsor fees; (3) animal drug establishment fees; and (4) animal drug product fees. Reduces or waives fees: (1) in excess of administrative costs; (2) that present a significant barrier to innovation; (3) if an animal drug application or supplemental animal drug application is intended solely for use of an animal drug in specified types of feed; (4) if an animal drug application or supplemental animal drug application is intended solely to provide for minor uses or use in minor species; or (5) for first applications by a small business.

Makes fees available for obligation only to the extent provided in advance in appropriations Acts. Offsets any excess fees against subsequent appropriations.

What's happening now October 2, 2003

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 3